Ex-Genentech CEO's anti-aging drug company starts first clinical trial
October 19, 2020 at 17:20 PM EDT
The first drug in a clinical trial from Calico's billion-dollar collaboration with AbbVie is a capsule focused on cancer immunotherapy.